Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
British Journal of Haematology|December 21, 2022
Relapse patterns in early-PET negative, limited-stage Hodgkin lymphoma (HL) after ABVD with or without radiotherapy-a joint analysis of EORTC/LYSA/FIL H10 and NCRI RAPID trialsValeria Fiaccadori, Anouk Neven, Catherine Fortpied, et al.
European Journal of Cancer (Oxford, England : 1990)|July 23, 2021
Efficacy thresholds for clinical trials with advanced or metastatic leiomyosarcoma patients: A European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group meta-analysis based on a literature review for soft-tissue sarcomasGeorgios Kantidakis, Saskia Litière, Anouk Neven, et al.
European Journal of Cancer (Oxford, England : 1990)|September 18, 2022
New benchmarks to design clinical trials with advanced or metastatic liposarcoma or synovial sarcoma patients: An EORTC - Soft Tissue and Bone Sarcoma Group (STBSG) meta-analysis based on a literature review for soft-tissue sarcomasGeorgios Kantidakis, Saskia Litière, Anouk Neven, et al.
Parasites & Vectors|March 16, 2024
Low diagnostic performance of thick blood smears of 50 µl in comparison with direct examination of 10 µl blood and the leukoconcentration technique of 5ml blood among loiasis-suspected patients with low microfilaremia in Gabon, Central Africa, using the STARD-BLCM guidelinesNoé Patrick M'Bondoukwé, Matthieu Owono-Medang, Marie Noëlle Moussavou-Boussougou, et al.
Clinical and Translational Science|September 18, 2024
Bioavailability of a novel sustained-release pellet formulation of 5-flucytosine in healthy-fed participants for use in patients with cryptococcal meningitisNabila Ibnou Zekri Lassout, Vishal Goyal, Edrich Krantz, et al.
Clinical and Translational Science|March 15, 2024
Bioavailability of three novel oral, sustained-release pellets, relative to an immediate-release tablet containing 500 mg flucytosine: A randomized, open-label, crossover study in healthy volunteersVishal Goyal, Edrich Krantz, Francois Simon, et al.
European Journal of Cancer (Oxford, England : 1990)|August 15, 2021
Long-term efficacy update of crizotinib in patients with advanced, inoperable inflammatory myofibroblastic tumour from EORTC trial 90101 CREATEPatrick Schöffski, Michaela Kubickova, Agnieszka Wozniak, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|October 4, 2023
EORTC 1409 GITCG/ESSO 01 - A prospective colorectal liver metastasis database for borderline or initially unresectable diseases (CLIMB): Lessons learnt from real life. From paradigm to unmet needMaike Collienne, Anouk Neven, Carmela Caballero, et al.
BJU International|October 27, 2021
Cytoreductive nephrectomy and exposure to sunitinib - a post hoc analysis of the Immediate Surgery or Surgery After Sunitinib Malate in Treating Patients With Metastatic Kidney Cancer (SURTIME) trialYasmin Abu-Ghanem, Johannes V van Thienen, Christian Blank, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 26, 2021
Short Androgen Suppression and Radiation Dose Escalation in Prostate Cancer: 12-Year Results of EORTC Trial 22991 in Patients With Localized Intermediate-Risk DiseaseMichel Bolla, Anouk Neven, Philippe Maingon, et al.
Pageof 4